Urol. praxi, 2013; 14(4): 178-182

How to manage pain

MUDr.Jiří Kozák, Ph.D.
Centrum pro léčení a výzkum bolestivých stavů při Klinice rehabilitace a tělovýchovného lékařství 2. LF UK a FN Motol, Praha

Pain is a complex phenomenon that is considered a symptom of acute conditions and a syndrome if it evolves into a chronic stage. Pain

can constitute a short informative or warning signal that is not always necessary to be treated, but it highlights some adverse reactions

of the organism or warning when a certain cause due to which an organism is harmed appears. The pain is described as acute, while sometimes

the notion „normal pain“ is used for the pain regularly encountered in sports, after some exertion or in degenerative diseases of old

age. Chronic pain is a continuing progression of painful symptomatology and it often has important bio–psycho–social consequences.

It needs to be therapeutically addressed in virtually all cases. In our paper, we focus in particular on the principles of pharmacotherapy,

which are based on the Guidelines drafted by a large group of experts. In recent years, with the arrival of new potent and rapidly acting

opioids for chronic pain conditions, particularly in oncology, attention has been paid to the diagnostics and treatment of breakthrough

pain, which is a frequent finding in the treatment of patients with slow release opioids. A special paragraph is devoted to the issue.

Keywords: acute pain, chronic pain, the WHO analgesic ladder, normal pain, analgesics league, breakthrough pain

Published: October 27, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kozák J. How to manage pain. Urol. praxi. 2013;14(4):178-182.
Download citation

References

  1. Rokyta R. Patofyziologie bolesti s ohledem na klinické souvislosti in Rokyta R, Kršiak M, Kozák J. Bolest. TIGIS, Praha, 2006: 77-86.
  2. Málek J. Konference o Bolesti, NNH 14. 12. 2007, přednáška: Pooperační bolest.
  3. Doležal T, Hakl M, Kozák J, Kršiak M, Lejčko J, Skála B, Sláma O, Ševčík P, Vorlíček J. Metodické pokyny pro farmakoterapii bolesti, Supplementum, Bolest, 2009; 2: 22-24.
  4. Raudenská J. Kognitivně behaviorální terapie u chronické bolesti. In.: Praško J, Možný P, Šlepecký M. Kognitivně behaviorální terapie psychických poruch. Praha/Kroměříž, Triton, 2007: 968-992.
  5. Raudenská J. Kognitivně behaviorální terapie specifické fobie u pacienta s chronickou bolestí - kazuistika. Bolest, 2007; 3: 142-155.
  6. Votava M, Doležal T, Kozák J, Vondráčková D. Adjuvantní léčiva v terapii bolesti: In: Bolest, Eds. Rokyta R, Kršiak M, Kozák J. Tigis, Praha 2006: 147-155.
  7. American Pain Society, Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, 5th ed. Glenview, IL: American Pain Society, 2003.
  8. Kršiak M, Kozák J, Lejčko J, Skála B, Vondráčková D. Farmakoterapie běžné bolesti. In: Bolest, Eds. Rokyta R, Kršiak M, Kozák J. Tigis, Praha 2006: 137-155.
  9. Oxford, http://www.jr2.ox.ac.uk/bandolier/booth/painpag/Acutrev/Analgesics/Leagtab.html.
  10. APS Congress, 20.-23. 3. 2003 American Pain Society, Chicago, USA.
  11. Tiskové prohlášení EMA na: http://www.ema.europa.eu.
  12. Projekt SOS (Safety Of non-Steroidal anti-inflammatory drugs) na: http://www.sos-nsaids-project.org/.
  13. Lovel TWI, Hassan WU. Clinicians' guide to Pain 1996: 81-171.
  14. Morita T, et al. J. Pain Symptoms Management 2005; 30: 96-103. Go to original source... Go to PubMed...
  15. Kozák J. Nové názory na dlouhodobou léčbu opioidy, Neurol. praxi, 2008; 9(1): 42-46.
  16. Eisenberg K, et al. Time to Modify the WHO Analgesic Ladder? in Pain Clinical Updates IASP, Volume XIII., No. 5; 2007.
  17. Cherny NI, Portenoy RK. In: Wall PD, Melzack R (Eds). Textbook of Pain, 4th ed. London: Churchill Livingstone, 1999; 1479-1522.
  18. ##
  19. Kozák J. Jak zvládnout bolest. Urol. praxi, 2013; 14(4): 178-182.
  20. EFIC's Declaration on Pain: Pain is as a major health problem, a disease in its own right; http://www.efic.org.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.